Frequently Asked Questions
The Middle East and Africa Point-of-Care Diagnostics Market size will be worth USD 2.47 billion by 2031 during the forecast period.
The Middle East and Africa Point-of-Care Diagnostics Market growth rate is 6.1% during the forecast period.
The Increasing Prevalence of Infectious Diseases and Growing Emphasis on Healthcare Infrastructure Development are the growth drivers of the Middle East and Africa Point-of-Care Diagnostics Market.
The product, prescription mode, type, platform, end user, and distribution channel are the factors on which the Middle East and Africa Point-of-Care Diagnostics Market research is based.
The major companies in the Middle East and Africa Point-of-Care Diagnostics Market are BioTech Africa (South Africa), Medtronic (Ireland), BioRad Laboratories, Inc. (U.S.), PTS Diagnostics (U.S.), Trinity Biotech (Ireland), Atlas Medical GmbH (U.K.), Abbott (U.S.), Sysmex Corporation (Japan), BIOMÉRIEUX (France), QuidelOrtho Corporation (U.S.), BD (U.S.), Sekisui Diagnostics (U.S.), F. HoffmannLa Roche Ltd (Switzerland), Beckman Coulter, Inc. (U.S.), ACON Laboratories, Inc. (U.S.), Nova Biomedical (U.S.), Siemens Healthcare GmbH (Germany).
